GlassScriptPhysician profile
Michael N Corradetti
NPI 1093977621
$3,073.95
in general payments reported to CMS, 2019-2025
15 companies · $56.67 in 2025
The $56.67 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.41 · 2021: $389 · 2022: $194 · 2023: $1,652 · 2024: $767 · 2025: $56.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $848 · Consulting Fee: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.41 |
| Travel and Lodging | $847.97 |
| Consulting Fee | $525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $1,108.87 | 2023 | Tomo Therapy System, Cyberknife System |
| Astrazeneca Pharmaceuticals LP | $756.95 | 2021-2024 | Imfinzi |
| Elekta, INC. | $279.17 | 2021-2024 | Elekta Medical Linear Accelerator |
| Monteris Medical Corporation | $190.89 | 2022-2023 | Neuroblate |
| Novocure INC. | $144.86 | 2021 | |
| Abbvie INC. | $124.56 | 2024 | |
| Progenics Pharmaceuticals, INC. | $120.31 | 2023 | Pylarify |
| E.R. Squibb & Sons, L.L.C. | $96.17 | 2021 | |
| Myriad Genetic Laboratories, INC. | $64.34 | 2022-2025 | Prolaris |
| Siemens Medical Solutions USA, INC. | $54.24 | 2023-2024 | Varian Ethos Treatment Planning |
| Novartis Pharmaceuticals Corporation | $52.16 | 2023-2024 | |
| Myovant Sciences INC. | $27.62 | 2022 | |
| Varian Medical Systems, INC. | $20.12 | 2021 | |
| Tempus Ai, INC | $18.28 | 2025 | Xt Cdx |
| Boston Scientific Corporation | $15.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Corradetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.